It contains a 40mg research formulation combining Retatrutide, BPC-157, and TB-500 in a precision pre-calibrated research pen
253 PengTJiDJiangY
Not for human or animal consumption, administration, diagnostic use, therapeutic use, or veterinary use
W., McCurrach, M
Retatrutide acts as a triple incretin receptor agonist, simultaneously activating three distinct receptors: GLP-1 receptors stimulating insulin secretion in a glucose-dependent manner, slowing gastric emptying, and reducing appetite GIP receptors enhancing insulin release and potentially improving fat metabolism Glucagon receptors increasing energy expenditure and promoting fat breakdown in the liver This multi-receptor activity produces pronounced effects on body weight, blood glucose, lipid metabolism, and hepatic fat
In addition to its support of neurological wellness, it also supports healthy reproductive function